• Delta 9 Cannabis (DN) has completed a private placement for gross proceeds of $206,250
  • The company issued 1,650,000 common shares at $0.1250 per share
  • Delta 9 Cannabis Inc. is a cannabis company focused on bringing the highest quality cannabis products to market
  • Delta 9 Cannabis Inc. (DN) opened trading at C$0.16

Delta 9 Cannabis (DN) has completed a private placement for gross proceeds of $206,250.

The company issued 1,650,000 common shares at $0.1250 per share. The securities issued will be subject to a statutory hold period expiring January 10, 2023.

The final closing remains subject to the approval of the TSX.

Delta 9 Cannabis is a cannabis company focused on bringing the highest quality cannabis products to market. Delta 9’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand.

Delta 9 Cannabis Inc. (DN) opened trading at C$0.16.

More From The Market Online

Buzz on the Bullboards: Challenges amid inflation and geopolitical tensions

Canadian and U.S. stock markets grapple with a host of challenges, from surging inflation data to escalating tensions in the Middle East.

Xebra Brands receives second CBD approval by Mexican authority

Xebra Brands (CSE:XBRA) announces it has received its second COFEPRIS approval for CBD product authorization in Mexico.
Canopy Growth - CEO, David Klein.

Canopy Growth shareholders approve Canopy USA asset strategy

After rearranging its capital structure, Canopy Growth (TSX:WEED) will be closer to establishing a U.S.-based multi-state operator.

The Market Online’s Weekly Cannabis Report – April 12, 2024

Canada’s cannabis stock market fluctuated this week thanks to a combination of industry-specific developments and broader market trends